Perrigo | PRGO - Loan Capital



Perrigo reported $3.62B in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
AbbVie USD 64.53B 4.19B Mar/2025
Abbott USD 12.93B 194M Jun/2025
Bayer EUR 31.71B 3.31B Jun/2025
Bristol-Myers Squibb USD 44.47B 1.69B Jun/2025
Corcept Therapeutics USD 0 0 Mar/2025
Dr.Reddys Laboratories INR 5.1B 2.77B Jun/2025
Eli Lilly USD 34.18B 319.4M Jun/2025
J&J USD 38.36B 7.7B Mar/2025
Merck USD 33.97B 484M Jun/2025
Nestle CHF 46.99B 4.71B Jun/2025
Pacira USD 378.1M 3.2M Jun/2025
Perrigo USD 3.62B 24.2M Jun/2025
Pfizer USD 57.5B 137M Jun/2025
Prestige Brands USD 1.01B 256K Jun/2025
Reckitt Benckiser GBP 7.24B 590M Dec/2024
Sanofi 13.2B 211M Jun/2025
Supernus Pharmaceuticals USD 0 0 Dec/2024
Teva Pharmaceutical Industries USD 16.76B 533M Jun/2025
Xeris Pharmaceuticals USD 218.63M 1.62M Jun/2025
Zoetis USD 5.23B 4M Jun/2025